Stem Cells (MSCs) Fail to Reduce Brain Inflammation in Active MS

Stem Cells (MSCs) Fail to Reduce Brain Inflammation in Active MS

310259

Stem Cells (MSCs) Fail to Reduce Brain Inflammation in Active MS

Into-the-vein treatment with mesenchymal stem cells (MSCs) failed to significantly reduce brain inflammation or improve clinical conditions among adults with active multiple sclerosis (MS) in an international Phase 2 clinical trial, according to final study data. The trial, which used magnetic resonance imaging (MRI) scans to assess the therapy’s efficacy, found the intravenous treatment was well-tolerated, but did not show any of the “demonstrated neuroprotective and ‘tissue healing’ properties [seen] in other studies,” the researchers…

You must be logged in to read/download the full post.